BDX

NYSE Becton, Dickinson and Company
Sep 29, 2026 · 4:59 AM ET LAST TRADE Market Closed

$181.70 ↓ -2.13 (-1.16%) Trading Down from the previous close of $183.83

YTD change
-6.37%
vs 20-day SMA
-0.56%
vs 200-day SMA
+6.32%

Price ranges

Previous day
$181.95 $184.34
open $183.07 close $183.83
+$0.76 (+0.42%)
Today
$0.00 $0.00
$181.70
Past week
$177.87 $184.37
from $180.70 now $181.70
+$1.00 (+0.55%)
Past month
$175.20 $191.76
from $189.52 now $181.70
-$7.82 (-4.13%)
This year
$140.11 $213.08
from $194.07 now $181.70
-$12.37 (-6.37%)

Price & Performance

+29.14 (+18.84%) / 6M

$136.61$156.44$176.27$196.10Mar 30Jun 29Sep 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 36.8% away from all-time highs of $287.32
  • BDX is down 6% since the beginning of the year
  • BDX is down 1% over the past 12 months
  • BDX is down 4% over the past 1 month
  • 4% of all BDX investors are betting against BDX
  • Number of investors short BDX has gone up 14% versus last month

BDX reads neutral: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is -0.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $3.23
Earnings momentum +20.6% Quarterly EPS growth
Quarterly change +20.6%

Valuation

P/E ratio 53.98
Enterprise value $66.5B
Beta -0.07

Balance sheet & scale

Income$1.2M
Revenue$20.1B
Cash$864.0M
Debt$16.8M
Income / Debt 0.07×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap $49.5B

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CDR CAD HEDGED $34.72 +0.35%
DXCM DexCom, Inc. $86.68 +0.07%
MDLN Medline, Inc. Class A $35.07 +1.07%
WST West Pharmaceutical Services, Inc. $375.65 +1.41%
TRUMY Terumo Corp Unsponsored ADR $14.52 -0.48%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.